Norris, A., Skaggs, V., Flynn, C., Georgemiller, R., Harper-Tam, J., & Guay-Terry, P. (2024). Review of SSRI Cases to Assess Potential for Cognitive Decline (Report No. DOT/FAA/AM-24/X). United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute. https://rosap.ntl.bts.gov/view/dot/74566
Norris, Ann, Valerie Skaggs, Christopher Flynn, Randy Georgemiller, Joanne Harper-Tam, and Peggy Guay-Terry. Review of SSRI Cases to Assess Potential for Cognitive Decline. Report no. DOT/FAA/AM-24/X. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2024. https://rosap.ntl.bts.gov/view/dot/74566.
Norris, Ann, et al. Review of SSRI Cases to Assess Potential for Cognitive Decline. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2024, Report no. DOT/FAA/AM-24/X, ROSA P. https://rosap.ntl.bts.gov/view/dot/74566.
This study investigated the impact of selective serotonin reuptake inhibitor (SSRI) use on the cognitive performance of pilots, aiming to assess the necessity and frequency of neurocognitive evaluations mandated by current aeromedical guidelines. This study was conducted among medically-certificated airmen with a psychiatric diagnosis that were previously approved for SSRI use and subsequently applied for a new medical certificate between October 2019 and January 2022. Utilizing data from medically-certificated airmen with psychiatric diagnoses and approved SSRI use, the study examined variables such as age, SSRI type, psychiatric diagnoses, cognitive tests, and comorbidities. The analysis employed logistic regression to determine associations with abnormal cognitive outcomes measured by CogScreen testing.
Norris, A., Skaggs, V., Flynn, C., Georgemiller, R., Harper-Tam, J., & Guay-Terry, P. (2024). Review of SSRI Cases to Assess Potential for Cognitive Decline (Report No. DOT/FAA/AM-24/X). United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute. https://rosap.ntl.bts.gov/view/dot/74566
Norris, Ann, Valerie Skaggs, Christopher Flynn, Randy Georgemiller, Joanne Harper-Tam, and Peggy Guay-Terry. Review of SSRI Cases to Assess Potential for Cognitive Decline. Report no. DOT/FAA/AM-24/X. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2024. https://rosap.ntl.bts.gov/view/dot/74566.
Norris, Ann, et al. Review of SSRI Cases to Assess Potential for Cognitive Decline. United States. Department of Transportation. Federal Aviation Administration. Office of Aviation. Civil Aerospace Medical Institute, 2024, Report no. DOT/FAA/AM-24/X, ROSA P. https://rosap.ntl.bts.gov/view/dot/74566.
ROSA P serves as an archival repository of USDOT-published products including scientific
findings, journal articles, guidelines, recommendations, or other information authored or co-authored by
USDOT or funded partners. As a repository, ROSA P retains documents in their original published format to
ensure public access to scientific information.
Links with this icon indicate that you are leaving a Bureau of Transportation
Statistics (BTS)/National Transportation Library (NTL)
Web-based service.
Thank you for visiting.
You are about to access a non-government link outside of
the U.S. Department of Transportation's National
Transportation Library.
Please note: While links to Web sites outside of DOT are
offered for your convenience, when you exit DOT Web sites,
Federal privacy policy and Section 508 of the Rehabilitation
Act (accessibility requirements) no longer apply. In
addition, DOT does not attest to the accuracy, relevance,
timeliness or completeness of information provided by linked
sites. Linking to a Web site does not constitute an
endorsement by DOT of the sponsors of the site or the
products presented on the site. For more information, please
view DOT's Web site linking policy.
To get back to the page you were previously viewing, click
your Cancel button.